Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL3884365 | 0.96 | SMN1; SMN2 (0.36) | THRBTSHRSMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL28251339 | 0.92 | TSHR (0.48) | THRBTSHRLMNAALDH1A1MEN1 | |
| SCHEMBL2944691 | 0.92 | THRB (0.44) | THRBTSHRSMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL541861 | 0.92 | TSHR (0.42) | THRBTSHRSMN1; SMN2LMNAALDH1A1 | |
| Allylamine SCHEMBL28314014 | 0.91 | THRB (0.33) | THRBTSHRSMN1; SMN2LMNA | |
| SCHEMBL541372 | 0.91 | TSHR (0.44) | THRBTSHRSMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL541106 | 0.89 | TSHR (0.47) | THRBTSHRSMN1; SMN2LMNAPOLB | |
| SCHEMBL541808 | 0.89 | TSHR (0.47) | THRBTSHRSMN1; SMN2LMNAPOLB | |
| SCHEMBL28062034 | 0.89 | TSHR (0.47) | THRBTSHRSMN1; SMN2LMNAPOLB | |
| SCHEMBL80350 | 0.89 | THRB (0.36) | THRBTSHRSMN1; SMN2LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713720-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4714453-A1 | USE OF STRUCTURE FOR NUCLEIC ACID DELIVERY IN TREATMENT OF HEMATOPOIETIC TUMOR | Japan Science and Technology Agency (JP) | 2026-03-25 | — | — | EP | claimed |
| WO-2025029684-A1 | LOW VOLUME RESUSCITANTS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF WASHINGTON (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024236526-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC. (CH) | 2024-11-21 | — | — | WO | claimed |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC (CH) | 2024-11-21 | — | — | US | claimed |
| US-12097113-B2 | Bioprosthetic valve and preparation method thereof | SICHUAN UNIVERSITY (CN) | 2024-09-24 | — | — | US | claimed |
| US-20240238325-A1 | Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-18 | — | — | US | claimed |
| US-20240189121-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2024-06-13 | — | — | US | claimed |
| EP-3666299-B1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2024-05-15 | — | — | EP | claimed |
| WO-2024051272-A1 | METHOD FOR CONSTRUCTING HYDROPHILIC ANTIFOULING COATING ON SURFACE OF MEDICAL IMPLANTABLE MATERIAL | 泰州度博迈医疗器械有限公司 | 2024-03-14 | — | — | WO | claimed |
| US-8252531-B2 | Using biopolymer comprising phosphorylcholine-like groups to prevent non-specific hybridization of nucleotide sequence; drug screening | NOF CORPORATION (JP) | 2012-08-28 | — | — | US | claimed |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2010-08-12 | — | — | US | claimed |
| US-20100094339-A1 | COATING COMPOSITIONS | COVIDIEN LP | 2010-04-15 | — | — | US | claimed |
| EP-2120824-A1 | COATING COMPOSITIONS | Tyco Healthcare Group LP (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008143654-A1 | COATING COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |
| EP-1764078-B1 | Microcapsules with aqueous core and their use in cosmetic compositions | OREAL (FR) | 2008-05-14 | — | — | EP | claimed |
| EP-1764078-A1 | Microcapsules with aqueous core and their use in cosmetic compositions | L'OREAL (FR) | 2007-03-21 | — | — | EP | claimed |
| EP-1206946-B1 | MEDICAL MATERIALS AND PROCESS FOR PRODUCING THE SAME | NOF CORP (JP) | 2006-08-30 | — | — | EP | claimed |
| US-6828028-B1 | Having surface treated with copolymer of such as ring opened glycidyl methacrylate and 2-(methacryloyloxy)ethyl-2-(tri-methylammonio)ethylphosphate; lubricity, blood compatible, safe, stable, durable | NOF CORPORATION (JP) | 2004-12-07 | — | — | US | claimed |
| EP-1206946-A1 | MEDICAL MATERIALS AND PROCESS FOR PRODUCING THE SAME | NOF CORPORATION (JP) | 2002-05-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | VCL, HBS1L, SAAL1 | THRB 1222/4885TSHR 2984/4885SMN1; SMN2 4643/4885 |
| US-20240238325-A1 | Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same | HNRNPH3, RNASEH1, HNRNPA1 | THRB 3469/4885TSHR 1640/4885SMN1; SMN2 796/4885 |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | PHOSPHO1, CUTA, SGMS1 | THRB 3607/4885TSHR 3000/4885SMN1; SMN2 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.